Celebrating a Decade of QuantSeq
30. January 2024
In the spirit of commemorating the remarkable journey of QuantSeq, Lexogen proudly presents exclusive behind-the-scenes interviews with key team members.
News & Blog
Read More ›
10 years of QuantSeq
30. January 2024
10 years of QuantSeq: applications of 3’ mRNA-Seq in inspiring scientific discoveries This year, Lexogen celebrates the 10th anniversary of
Classical Single-Cell RNA Sequencing: a comprehensive overview
3. January 2024
The roots of classical single-cell RNA sequencing (scRNA-Seq) trace back to the desire and need to capture the nuances of
Lexogen Unveils LUTHOR High-Definition Single Cell 3’ mRNA-Seq Kit, Revolutionizing Single-Cell RNA Sequencing
14. November 2023
Vienna, November 14, 2023 / PRNewswire – Lexogen, a pioneer in the field of genomics and transcriptomics, is proud to
Lexogen’s LUTHOR HD Application Note has been published in Nature: Advancing High-Definition Single-Cell RNA Sequencing
8. November 2023
Vienna, November 8, 2023 / PRNewswire – Lexogen is proud to be featured in Nature Methods with a Technical Application
RNA Sequencing in Drug Discovery and Development
10. October 2023
Introduction Drug discovery and development is an elaborate and lengthy process, and researchers are constantly seeking innovative tools
Paper talk with Michael Schon, Phd – Bridging gaps in transcript assembly
29. August 2023
In higher eukaryotes, multiple transcript isoforms can originate from a single gene, diversifying the transcriptome and, consequently, the proteome. Transcript
Excellence is in Precision: PCR Add-on and Reamplification Kit V2
13. July 2023
Lexogen releases a new PCR Add-on and Reamplification Kit V2 that combines reagents for qPCR and library reamplification in one
Lexogen achieves ISO 13485:2016 quality management certification
21. June 2023
Vienna, June 21 , 2023 /PRNewswire/– Lexogen, a leading provider of innovative next-generation sequencing solutions, is pleased to announce that
Harnessing the Power of RNA-Seq in RNA Therapeutics: A Valuable Tool for Discovery and Testing
16. June 2023
RNA therapeutics are a rapidly expanding category of drugs based on RNA with great potential against systemic diseases, such
Lexogen releases a new solution that stabilizes fragile RNA molecules from degradation
23. May 2023
Does your experiment call for numerous samples, and you want to ensure the RNAs remain intact before you can proceed
Lexogen’s Technical Support: The Best in the Industry
23. May 2023
When it comes to choosing a technology provider, technical support is a critical factor to consider. Whether you are a
Categories
Lexogen GmbH
Campus Vienna Biocenter 5
1030 Vienna, Austria
Telephone:
+43 (0) 1 345 1212
Sales support:
+43 (0) 1 345 1212-42
Technical support:
+43 (0) 1 345 1212-41
Working hours: 9:00 – 17:00 (CET)
Fax: +43 (0) 1 345 1212-99
Email: info@lexogen.com
Company number: FN 297318 h
VAT number: ATU63622048
Lexogen, Inc.
51 Autumn Pond Park
Greenland, NH 03840, US
Telephone:
+1-603-431-4300 ext.0
+1-877-Lexogen
(+1-877-539-6436) ext. 0
Sales inquiries:
Northeast: +1-312-978-6413
Southeast: +1-615-968-3325
Northwest: +1-415-726-4318
Southwest: +1-520-934-0678
Technical support:
+1-949-767-1631
(Working hours: 9:00 – 17:00 (EST))
+1-603-498-1666
(Working hours: 7:30 – 15:30 (CST))
Fax: +1-603-431-4333
Lexogen Newsletter
Subscribe to our mailing list to be among the first to get updates from us!
Copyright © 2026 Lexogen GmbH. All rights reserved | Impressum | Privacy Policy | Terms and Conditions | Whistleblowing
Cart
Product
Product Short Description
PRICE
Product
Product Short Description
PRICE
Product
Product Short Description
PRICE